From Software-Defined Machines to Physical AI: Why medical technology and defence are converging around the same systems challenge. At Hydrix, we work …
News & Articles
Hydrix Secures A$3.4 Million Medical Robotics Development Contract with US-based Remedy Robotics
Hydrix Limited (ASX: HYD) (Hydrix) is pleased to announce it has secured a significant (A$3.4M) engineering development contract with US-based physical…
Hydrix Announces Quantanosis Engagement Supporting Development of Advanced AI Robotic Stroke Treatment Platform
Quantanosis is developing a novel non-invasive platform that combines advanced robotics, artificial intelligence and Histotripsy ultrasound with the goal …
International Women in Engineering Day: Chrissy’s Journey from Intern to Student Engineer
For International Women in Engineering Day, we wanted to celebrate the next generation of engineers and the opportunities that can shape a career ….
Hydrix Signs Contract to Advance Phasor Innovation’s Quantum Sensing & Navigation Technology
Hydrix Limited (ASX: HYD) advises it signed a new contract with Phasor Innovation (“Phasor”) to continue to support Phasor’s development of its advanced …
Hydrix signs binding contract with the NIOA Group to advance Australian counter-UAS Defence capability
Hydrix Limited (Hydrix) (ASX: HYD) advises it has signed a binding contract with the NIOA Group to support the design, development and integration of NIOA’s …
The challenges of Transcutaneous Energy Transfer (TET)
Tesla’s vision is closer to reality than ever, particularly in the field of implantable medical devices. Transcutaneous Energy Transfer (TET) enables wireless power delivery across intact skin
Hydrix enters A$2.5m contract to commence development of SynCardia’s next generation TAH
Hydrix Ltd (ASX: HYD) today announced that its wholly owned subsidiary Hydrix Services Pty Ltd (“Hydrix”) entered into a contract with SynCardia Systems LLC (“SynCardia”), a wholly owned …
Engineering Australia’s Edge: Building sovereign capability through reliable control systems
Australia’s defence priorities are shifting toward strategic independence and technical self-reliance. As programs in drones, counter-drone systems, electronic warfare, and reconnaissance expand, so too
Why cardiac device innovation depends on proven platforms
The global cardiovascular devices market is on the rise. Analysts estimate it will grow from about USD 84.8 billion in 2023 to USD 140 billion by 2033, driven by innovation across diagnostics, therapies
How one man’s journey helped inspire new voices in cardiac technology
In 2022, Hydrix, a global leader in cardiac circulatory assist technologies and a foundation sponsor of the inaugural Heart Hackathon, helped launch a new international competition to design a total artificial heart.
Celebrating a Significant Breakthrough in Total Artificial Heart Development
Last week, the world witnessed an extraordinary milestone in Mechanical Circulatory Support (MCS) – the successful implantation of BiVACOR Total Artificial Heart (TAH) in a patient in Australia.
Guiding Innovation: Gyder Surgical’s Journey to 510(k) Clearance
Bringing a breakthrough medical technology to market is often a challenging journey, one that requires vision, expertise, and above all, persistence. Gyder Surgical has exemplified this path…
From insight to impact: reducing risk in medical device investment
In funding new medical device development, where stakes are high and commercialization paths are complex, confidence is crucial. Today’s decision-makers need more than just a promising…
Rethinking mechanical circulatory support: the art of connection
Our creative vision for a next-generation MCS controller is rooted in the idea of connection. Our brief is to generate ideas as to how the controller might connect with the patient on a more ….
Navigating the evolving landscape of cybersecurity in medical devices
Cybersecurity has become a pivotal concern in the realm of medical devices, driven by the rapid advancements in technology and the increasing connectivity of these devices.
Electronic Component Sourcing for Class III Medical Devices
There are numerous challenges to be considered when selecting components for Class III devices. Hydrix engineer Chris Sam Soon shares his…
Navigating the challenges of the healthcare robot revolution
Understanding the Landscape of Medical Robotics The medical robotics industry is at a tipping point. Challenges facing developers are broad including…
Navigating the most effective Quality System for Medical Device Startups
In the intense world of medical device startups, the importance of a robust quality system often takes a backseat to…
Celebrating the Winners of the Inaugural Heart Hackathon
In a culmination of more than a year’s worth of dedication, enthusiasm, and innovation, today we celebrate the outstanding achievement…
Conquering the EU MDR/IVDR with a well-defined regulatory strategy
Introduction Medical device regulations worldwide are evolving to adapt to technology advancements, address emerging risks, enhance patient safety, and improve…
POC development in a post-COVID-19 world
Hydrix recently undertook a market research initiative focusing on the in-vitro diagnostics/point-of-care (IVD/POC) market, engaging with key stakeholders in the…
Refreshing the Hydrix brand
As an emerging leader in medical technology design, distribution, and investment, we are thrilled to announce the launch of our…
Achieving excellence in diverse safety-critical projects
Safety–critical design engineering underpins many of the products and processes used in high-assurance applications. Hydrix’s track record extends to 20+…